Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside. [electronic resource]
- Current neuropharmacology 2019
- 861-873 p. digital
Publication Type: Journal Article; Review
1875-6190
10.2174/1570159X16666180830100754 doi
Alanine--analogs & derivatives Antiparkinson Agents--therapeutic use Benzylamines--therapeutic use Dopamine Agents--therapeutic use Humans Indans--therapeutic use Levodopa--therapeutic use Male Monoamine Oxidase Inhibitors--therapeutic use Parkinson Disease--drug therapy Selegiline--therapeutic use